1[1]Green L L, Hardy M C, Magnard Currie C E, et al. Antigen-specific human monodonal antibodies from mice engineered with human Ig heavy and crgat dnain YACs.Nat Genet, 1994,7: 13-21.
2[2]Ishida I, Yoshida H, Tomizuka K. Production of a diverse repertoire of human antibodies in geretically engineered mice.Microbiol Immunol, 1998,429: 143-150.
3[3]Gerd R,Leonard S, Clarence W, et al. Serological analysis of human anti-human antibody response in colon cancer patients treated with repented dose of humanized monoclonal antiboly A33.Cancer Res,2001, 61:6851-6859.
4[4]Gundram J, Martina B, Wilhelm E, et al. Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situ T-cell activation and therapeutic efficacy. Int J Cancer, 2001, 91: 225-230.
5[5]Konstantin M, Peter K, Matthias M, et al. Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity. Int J Cancer, 2001, 93:409-416.
6[6]Srivastava P K, Menoret A, Basu S, et al. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive word.Immunity, 1998, 8: 657-665.
7[7]Janetzki S, Palla D, Rosenhauer V, et al. Immunization of cancer patients with autologous cancer-dedrived heat shock protein gp96 preparations: A pilot study.Int J Cancer, 2000, 88: 232-238.
8[8]Chu N R, Wu H B, Wu T, et al. Immunotherapy of a human papilomavirus (HPV) type 16 E7-expressing tumor by administration of fusion protein comprising mycobacterium bovis bacille calmette guerin (BCG) HSP 65 and HPV 16E7.Clin Exp Immunol,2000, 121:216-225.
9[9]de Fatta R J, Nathan C A, de Benedtti A. Antisense RNA to eIF4E suppresses oncogenic of a head and neck squamous cell carcinoma cell line.Laryngoscope, 2000, 110:928-933.
10[10]Tadashi, Yasuko, Takao, et al. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerse catalytic subunit (human telomerse reverse transcriptase) gene promoter.Cancer Res, 2001, 61:5796-5802.
